Search
Now showing items 1-4 of 4
Treatment of bacterial infection with oral interferon-α
(United States. Patent and Trademark Office, 1998-10-06)
Bacterial infections are treated by the administration of alpha-interferon at a dosage of from about 0.1 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and pharyngeal mucosae. The ...
Treatment of neoplastic disease with oral interferon
(United States. Patent and Trademark Office, 1998-10-20)
Neoplastic diseases are treated by the administration of human interferon, particularly IFN-α, at a dosage of from about 0.01 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and ...
Treatment of viral disease with oral interferon-α
(United States. Patent and Trademark Office, 1998-11-03)
Viral infections are treated by the administration of alpha-interferon at a dosage of from about 0.01 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and pharyngeal mucosae. The ...
Treatment of autoimmune disorders with oral interferon
(United States. Patent and Trademark Office, 1998-12-08)
Autoimmune disorders are treated by the administration of human interferon, particularly IFN-α or IFN-β, at a dosage of from about 0.01 to about 5 IU/lb./day such that the interferon is held in contact with the patient's ...